Abstract:Emerging evidence suggests that accumulation of oxidative DNA damage in nuclear genome is an important contributing factor in neuronal cell death after cerebral ischemia. It has been shown in various models of cerebral ischemia/reperfusion that there is accumulation of oxidative DNA base damage and apurinic/apyridinic abasic site (AP site) in injured neurons, which could mediate neuronal degeneration by triggering various pro-apoptotic molecules. In the brain most types of oxidative DNA damage are repaired via the base-excision repair (BER) pathway that is highly inducible in response to various sublethal stimuli. Thus, interventions that enhance the activity of the BER pathway may be a potential therapeutic strategy against ischemic cell death. In the present study, we have examined the neuroprotective effect of the neuropeptide pituitary adenylate cyclase activating polypeptide (PACAP) in the rat model of transient global cerebral ischemia. Further, we have investigated the role of BER regulation as a potential mechanism underlying the effect of PACAP. PACAP, when infused intracerebroventricularly in the rat, potently protected against CA1 neuronal cell death after global cerebral ischemia produced by 12 minutes of 4-vessel occlusion. Associated with this neuroprotection, PACAP treatment reduced the accumulation of oxidative DNA lesions, especially AP site, and subsequently attenuated the activation of pro-apoptotic molecules p53 and PUMA in the CA1 sector, suggesting that the effect of PACAP may involve the acceleration of the repair process of endogenous oxidative DNA damage. To investigate the underlying mechanism, cellular BER activity and the expression of BER enzymes were measured in the hippocampal extracts. The results revealed that PACAP markedly enhanced the hippocampal expression (at both mRNA and protein levels) and activities of the essential BER enzymes AP endonuclase (APE) and DNA polymerase-beta. Furthermore, based on the results of inhibition studies, the inducible effect of PACAP on the BER pathway was found to be dependent on the phosphorylation and nuclear translocation of cAMP-response-element-binding protein (CREB), which mediated the enhanced transcription of both APE and DNA polymerase-beta. Finally, the effect of PACAP on BER and neuroprotection was mimicked by the administration of a cAMP/protein kinase A (PKA) agonist. The results of the present study demonstrate the neuroprotective effect of PACAP in hippocampal CA1 neurons after transient global cerebral ischemia. The effect of PACAP is dependent on the activation and nuclear translocation of CREB, and involves CREB-mediated activation of BER pathway for endogenous DNA repair. The results suggest that enhancement of neuronal DNA repair capacity by PACAP or other means may be a novel potential therapeutic approach to limit ischemic neuronal loss. (This project was supported by NIH grants NS36736, NS38560, NS 43802, and NS45048).

Effects of gene expression of endogenous PACAP and PAC1 receptor in PC12 cells under administration of rotenone and neuropeptide PACAP

The neuropeptide PACAP27 protected PC12 cells against rotenone-induced neurotoxicity

The Mechanism of Neuroprotective Effect of PACAP27 on Rotenone-Induced Apoptosis in PC12 Cells

PACAP protects neuronal differentiated PC12 cells against the neurotoxicity induced by a mitochondrial complex I inhibitor, rotenone.

Positive allosteric regulation of PAC1-R up-regulates PAC1-R and its specific ligand PACAP

Positive allosteric regulation of PAC1-R up-regulates<?A3B2 ACK?>PAC1-R and its specific ligand PACAP

Positive Allosteric Regulation of PAC1-R Up-Regulates&lt;?a3b2 ACK?&gt;PAC1-R and Its Specific Ligand PACAP

Molecular Mechanism for PACAP 38-Induced Neurite Outgrowth in PC12 Cells

PACAP38 Differentially Effects Genes and CRMP2 Protein Expression in Ischemic Core and Penumbra Regions of Permanent Middle Cerebral Artery Occlusion Model Mice Brain

Neuroprotection against ischemic CA1 neurodegeneration by pituitary adenylate cyclase activating polypeptide via cAMP-response-element-binding protein-mediated enhancement of endogenous DNA repair

Therapeutic Effect of Neuropeptide PACAP27 on Parkinson's Disease in Mice

Pituitary adenylate cyclase-activating polypeptide induces translocation of its G-protein-coupled receptor into caveolin-enriched membrane microdomains, leading to enhanced cyclic AMP generation and neurite outgrowth in PC12 cells.

PACAP protects cerebellar granule neurons against oxidative stress-induced apoptosis

Expressions of endogenous pituitary adenylate cyclase-activating polypeptide following acute spinal cord injury in rats

Effects of Pituitary Adenylate Cyclase Activating Polypeptide and Its Fragments on Retinal Degeneration Induced by Neonatal Monosodium Glutamate Treatment

Pituitary Adenylate Cyclase Activating Polypeptide Attenuates the Neurotoxicity Mediated by Nitric Oxide

Pituitary Adenylate Cyclase Activating Polypeptide Elicits Neuroprotection Against Acute Ischemic Neuronal Cell Death Associated with NMDA Receptors

Mechanism of cytotoxicity induced by rotenone in PC12 cells

Neuroprotective Effects of Pacap27 in Mice Model of Parkinson'S Disease Involved in the Modulation of K(Atp) Subunits and D2 Receptors in the Striatum

EXPERIMENTAL STUDY OF PITUITARY ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE ON RELIEVING BRAIN EDEMA INDUCED BY ISCHEMIA IN RATS

Neuropeptide Pacap in Mouse Liver Ischemia and Reperfusion Injury: Immunomodulation by the Camp-Pka Pathway